WO2019059392A1 - Nettoyant pour la peau sous forme de mousse - Google Patents

Nettoyant pour la peau sous forme de mousse Download PDF

Info

Publication number
WO2019059392A1
WO2019059392A1 PCT/JP2018/035298 JP2018035298W WO2019059392A1 WO 2019059392 A1 WO2019059392 A1 WO 2019059392A1 JP 2018035298 W JP2018035298 W JP 2018035298W WO 2019059392 A1 WO2019059392 A1 WO 2019059392A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
fatty acid
foam
skin cleanser
polyethylene glycol
Prior art date
Application number
PCT/JP2018/035298
Other languages
English (en)
Japanese (ja)
Inventor
拓也 山科
俊樹 藤本
康輝 稲田
Original Assignee
株式会社マンダム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017183578A external-priority patent/JP7121476B2/ja
Application filed by 株式会社マンダム filed Critical 株式会社マンダム
Priority to KR1020197033224A priority Critical patent/KR20190133782A/ko
Priority to CN201880030689.9A priority patent/CN110612094A/zh
Publication of WO2019059392A1 publication Critical patent/WO2019059392A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66—Non-ionic compounds
    • C11D1/74—Carboxylates or sulfonates esters of polyoxyalkylene glycols
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/04—Detergent materials or soaps characterised by their shape or physical properties combined with or containing other objects
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/08—Liquid soap, e.g. for dispensers; capsuled
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/20—Organic compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds

Definitions

  • the present invention relates to foam skin cleansers.
  • foam skin cleansing agents such as face wash and hand soap
  • foam skin cleansing agents that form bubbles by discharging from pump-type or aerosol-type former containers are known as ones that can be easily foamed during use.
  • Patent Documents 1 to 3 properties such as ease of foaming (foaming power), foam quality, and foam persistence (foam retention) are emphasized.
  • the foam for example, a dense and creamy foam having a fine foam formed at a high density is required.
  • a detergent containing a higher fatty acid salt as a main surfactant component as in Patent Document 1 has high foaming power and is excellent in foam quality.
  • the skin may feel firm after washing.
  • the higher fatty acid salt may be precipitated to cause discharge failure, so it is necessary to take measures to suppress the precipitation.
  • detergents that do not contain higher fatty acid salts such as Patent Documents 2 and 3, may be inferior in terms of foaming power and fineness of foam.
  • An object of the present invention is to provide a foamy skin cleanser which contains a higher fatty acid and / or a salt thereof and suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acid.
  • the present invention is a foam-like skin cleansing agent in which an undiluted solution and a propellant are filled in an aerosol container, and the undiluted solution contains the following component A, component B, component C, and component D. It relates to a foam skin cleanser.
  • Component A Higher fatty acid and / or salt thereof
  • Component B Fatty acid ester oil component liquid at room temperature
  • Component C Water component D: Polyethylene glycol fatty acid ester type nonionic surfactant
  • a foamy skin cleanser which suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids while containing higher fatty acids and / or salts thereof.
  • the foam skin cleanser of the present invention is one in which an undiluted solution and a propellant are filled in an aerosol container.
  • the foamy skin cleanser of the present invention forms a foam during use, i.e. when discharged from the aerosol container and / or after adhering to a subject.
  • each component of the foam-like skin cleanser of the present invention will be described.
  • the above stock solution contains component A: higher fatty acid and / or a salt thereof, component B: fatty acid ester oil liquid at room temperature, component C: water, and component D: polyethylene glycol fatty acid ester type nonionic surfactant as essential components contains.
  • stock solution further contains component E: polyhydric alcohol, component F: thickening compound etc. in addition to the said essential component. Further, components (other components) other than the components A to F may be further contained. The components A to F and other components may be used alone or in combination of two or more.
  • Component A is a higher fatty acid and / or a salt thereof, that is, one or both of a higher fatty acid and a higher fatty acid salt.
  • the component A acts as a cleansing component to enhance the detergency of the foamy skin cleansing agent, and is effective for improving the foamability and latheriness of the foamy skin cleansing agent. Furthermore, it is effective to form a dense foam having a high foam density.
  • the said component A may use only 1 type, and may use 2 or more types.
  • higher fatty acids examples include higher fatty acids having 12 to 22 carbon atoms such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid and behenic acid; vegetable oils and fats such as olive oil, coconut oil, palm oil and cottonseed oil And animal fats and oils such as fish oil and beef tallow.
  • higher fatty acids having 12 to 22 carbon atoms are preferable, and lauric acid, myristic acid, palmitic acid and stearic acid are more preferable, from the viewpoints of detergency, foamability and foaminess of foam skin cleansing agents.
  • salts of the above-mentioned higher fatty acid salts include alkali metal salts such as sodium salt and potassium salt; and alkanolamine salts such as monoethanolamine salt, diethanolamine salt and triethanolamine salt.
  • the higher fatty acid salt may be blended with the higher fatty acid salt previously prepared to be a salt, or the higher fatty acid and the base may form a salt in a stock solution.
  • the content of Component A in 100% by mass of the stock solution is preferably 0.1 to 10.0% by mass, more preferably 0.5 to 8.0% by mass, and still more preferably 1.0 to It is 5.0 mass%.
  • the content is 0.1% by mass or more, the foam resistance is further improved, which is preferable.
  • the clogging of the aerosol by precipitation of the component A is further suppressed because the said content is 10.0 mass% or less, it is preferable.
  • the said content is a total amount of content (The content when converted as a higher fatty acid) of all the components A contained in a undiluted
  • Component B is a fatty acid ester oil which is liquid at room temperature.
  • fatty acid ester oil which is liquid at room temperature is one having a viscosity (B-type viscometer: VISCOMETER TV-25 (manufactured by Toki Sangyo Co., Ltd.)) of 100 mPa ⁇ s or less at 25 ° C. Point to It has been newly found that Component B has the effect of suppressing precipitation of Component A, in addition to suppressing the feeling of skin firmness after washing.
  • the said component B may use only 1 type, and may use 2 or more types.
  • ester oil of linear fatty acid and branched lower alcohol for example, ester oil of linear fatty acid and linear higher alcohol, ester oil of linear fatty acid and branched higher alcohol, branched fatty acid and linear
  • ester oils with higher alcohols for example, ester oils with branched fatty acids and branched higher alcohols, ester oils with fatty acids and polyhydric alcohols, and ester oils with dibasic acids.
  • ester oil of the linear fatty acid and the branched lower alcohol examples include isopropyl myristate, isopropyl palmitate, and isopropyl linoleate.
  • ester oil of linear fatty acid and linear higher alcohol examples include cetyl caprylate, hexyl laurate, decyl myristate, decyl oleate, and oleyl oleate.
  • ester oils of linear fatty acids and branched higher alcohols include isostearyl laurate, isotridecyl myristate, 2-hexyldecyl myristate, isostearyl myristate, octyldodecyl myristate, 2-ethylhexyl palmitate, palmitin Isocetyl acid, isostearyl palmitate, 2-ethylhexyl stearate, isocetyl stearate, isodecyl oleate, octyldodecyl oleate, octyldodecyl linoleate and the like.
  • ester oil of the branched fatty acid and the linear higher alcohol examples include cetyl 2-ethylhexanoate, cetostearyl 2-ethylhexanoate, stearyl 2-ethylhexanoate, and hexyl isostearate.
  • ester oils of the above branched fatty acids and branched higher alcohols include 2-hexyldecyl 2-ethylhexanoate, isostearyl 2-ethylhexanoate, octyldodecyl dimethyl octanoate, 2-ethylhexyl isopalmitate, and isocetyl isostearate.
  • isostearic acid isostearyl, octyldodecyl isostearate, and isononyl isononanoate, and the like.
  • ester oils of fatty acids and polyhydric alcohols include ethylene glycol dioleate, propylene glycol dicaprylate, propylene glycol di (caprylic capric acid), propylene glycol dicaprate, propylene glycol dicaprate, and neopentyl glycol dicaprate.
  • ester oil of the dibasic acid examples include diisopropyl adipate, diisobutyl adipate, dioctyl adipate, diisopropyl sebacate, dioctyl sebacate and the like.
  • the content of component B in 100% by mass of the stock solution is preferably 0.1 to 5.0% by mass, more preferably 0.3 to 4.0% by mass, and still more preferably 0.5 to It is 3.0 mass%.
  • the said content is 0.1 mass% or more, in order to suppress the pinch feeling of the skin after washing
  • the said content is 5.0 mass% or less, in order to maintain foaminess, it is preferable.
  • the above content is the total amount of the content of all the components B contained in the stock solution.
  • the stock solution may optionally further contain a fatty acid ester oil which is solid at room temperature.
  • fatty acid ester oil which is solid at room temperature means that 50 g of fatty acid ester oil is placed in a 70 mL mayonnaise bottle at 25 ° C., and this container is inclined at 45 ° for 30 seconds. It does not run down, it is a thing from the paste to the solid state.
  • the fatty acid ester oil which is solid at room temperature has the effect of suppressing the firmness of the skin after washing and forming a fine, firm and dense foam of texture.
  • One type of fatty acid ester oil which is solid at room temperature may be used, or two or more types may be used.
  • the content of the fatty acid ester oil solid at room temperature in 100% by mass of the stock solution is preferably 0.01 to 4.0% by mass, more preferably 0.05 to 3.5% by mass, and further Preferably, it is 0.1 to 3.0% by mass.
  • the content is 0.01% by mass or more, it is preferable in order to suppress the feeling of firmness of the skin after washing and to form a fine, firm and dense foam of texture.
  • cleaning can be suppressed by the said content being 4.0 mass% or less, it is preferable.
  • the above content is the total content of all room temperature solid fatty acid ester oils contained in the stock solution.
  • the water of Component C is not particularly limited as long as it can be used as a cosmetic raw material, but in general, purified water is preferably used.
  • the content of the component C in 100% by mass of the stock solution is preferably 60.0% by mass or more, more preferably 70.0% by mass or more, from the viewpoint of preventing solidification of the discharged matter, and liquefaction of the discharged matter From the viewpoint of preventing, 98.0 mass% or less is preferable, and 90.0 mass% or less is more preferable.
  • Component D is a polyethylene glycol fatty acid ester type nonionic surfactant.
  • the component D can more effectively suppress the precipitation of the component A.
  • it forms a dense foam with a high foam density, and exhibits the effect of improving the foam resistance of the foam.
  • the said component D may use only 1 type, and may use 2 or more types.
  • component D the component chosen from polyethyleneglycol fatty acid monoester and polyethyleneglycol fatty acid diester is mentioned, for example.
  • polyethylene glycol fatty acid monoester examples include polyethylene glycol monolaurate, polyethylene glycol monostearate, polyethylene glycol monoisostearate, and polyethylene glycol monooleate.
  • polyethylene glycol fatty acid diester examples include polyethylene glycol dilaurate, polyethylene glycol distearate, polyethylene glycol diisostearate, and polyethylene glycol dioleate.
  • the fatty acid in the component D is preferably a fatty acid having 8 to 24 carbon atoms, more preferably a fatty acid having 10 to 20 carbon atoms, and still more preferably a carbon number, from the viewpoint of more effectively suppressing precipitation of the component A.
  • the average addition mole number of ethylene oxide in the component D is preferably 10 to 300, more preferably 12 to 250, from the viewpoint of more effectively suppressing the precipitation of the component A.
  • component D it is preferable to use a component selected from polyethylene glycol monostearate, polyethylene glycol monoisostearate, polyethylene glycol distearate, and polyethylene glycol diisostearate.
  • the content of component D in 100% by mass of the stock solution is preferably 0.01 to 5.0% by mass, more preferably 0.05 to 4%, from the viewpoint of more effectively suppressing precipitation of component A.
  • the content is 0.1% by mass, more preferably 0.1 to 2.0% by mass.
  • the above content is the total amount of the content of all the components D contained in the stock solution.
  • the stock solution may optionally further contain a nonionic surfactant such as a sorbitan fatty acid ester type nonionic surfactant.
  • a nonionic surfactant such as a sorbitan fatty acid ester type nonionic surfactant.
  • sorbitan fatty acid ester type nonionic surfactants are effective for the formation of firm and dense bubbles.
  • Nonionic surfactants other than component D may use only 1 type, and may use 2 or more types.
  • sorbitan fatty acid ester type nonionic surfactant examples include a component selected from sorbitan fatty acid ester and ethylene oxide condensate of sorbitan fatty acid ester.
  • sorbitan fatty acid esters examples include sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan monoisostearate, sorbitan monooleate, sorbitan coconut oil fatty acid, sorbitan sesquistearate, sorbitan sesquiisostearate, sesquiolein Sorbitan acid, sorbitan distearate, sorbitan tristearate, sorbitan trioleate and the like can be mentioned.
  • Examples of the ethylene oxide condensates of sorbitan fatty acid esters include polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan monoisostearate, and polyoxyoleate monooleate.
  • Examples thereof include ethylene sorbitan, coconut oil fatty acid polyoxyethylene sorbitan, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate.
  • the fatty acid in the sorbitan fatty acid ester type nonionic surfactant is preferably a fatty acid having 8 to 24 carbon atoms, more preferably 10 carbon atoms, from the viewpoint of exerting firm and dense foam formation more effectively. It is a fatty acid of ⁇ 20, more preferably a fatty acid having 12 to 18 carbon atoms.
  • the average addition mole number of ethylene oxide when the sorbitan fatty acid ester type nonionic surfactant is an ethylene oxide condensate is preferably 5 to 10 from the viewpoint of exerting firm and dense foam formation more effectively. 200, more preferably 6 to 150.
  • sorbitan monopalmitate coconut oil fatty acid sorbitan
  • poly monopalmitate from the viewpoint of exerting firm and dense foam formation more effectively. It is preferable to use a component selected from oxyethylene sorbitan, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monoisostearate, polyoxyethylene sorbitan tristearate, and polyoxyethylene sorbitan trioleate, and coconut oil fatty acid sorbitan It is more preferable to use a component selected from polyoxyethylene sorbitan monostearate and monostearate.
  • the content of the sorbitan fatty acid ester type nonionic surfactant in 100% by mass of the stock solution is From the viewpoint of forming a dense foam, preferably 0.05 to 5.0% by mass, more preferably 0.1 to 4.0% by mass, and still more preferably 0.1 to 3.0%. It is mass%.
  • the above content is the total content of the contents of all sorbitan fatty acid ester type nonionic surfactants contained in the stock solution.
  • the stock solution preferably further contains a polyhydric alcohol of component E.
  • Component E can more effectively suppress precipitation of component A.
  • the said component E may use only 1 type, and may use 2 or more types.
  • sugar alcohols such as sorbitol, maltitol, glucosyltrehalose, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, isoprene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol (1 (1, 3-butanediol), 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin (1,2,3-butanediol) Propanetriol), diglycerin, polyglycerin, polyoxyethylene methyl glucoside, polyoxypropylene methyl glucoside, etc., and from the viewpoint of being able to alleviate the feeling of skin firmness after washing, and from the viewpoint of making the lather good Et al, it is preferred to include a sugar alcohol.
  • the content of component E in 100% by mass of the stock solution is preferably 0.5 to 20.0% by mass, more preferably 1.0 to 15%, from the viewpoint of more effectively suppressing precipitation of component A.
  • the content is 0.1% by mass, and more preferably 1.0 to 10.0% by mass.
  • the content is the total of the content of all the components E contained in the stock solution.
  • the stock solution further contains a thickening compound selected from component F1: xanthan gum and guar gum; and a component F such as a thickening compound selected from component F2: hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose: thickening compound Is preferred.
  • a thickening compound selected from component F1: xanthan gum and guar gum such as a thickening compound selected from component F2: hydroxypropyl methylcellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose: thickening compound Is preferred.
  • the thickening compound of component F has the effect of improving the foam resistance.
  • the said component F may use only 1 type and may use 2 or more types, it is preferable to use the component F1 and the component F2 together.
  • the content of the component F1 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.03 to 0.4% by mass from the viewpoint of improving the foam resistance. And more preferably 0.05 to 0.3% by mass.
  • the said content is a total amount of content of all the components F1 contained in a undiluted
  • the content of the component F2 in 100% by mass of the stock solution is preferably 0.01 to 0.5% by mass, more preferably 0.02 to 0.4% by mass from the viewpoint of improving the foam resistance. It is more preferably 0.03 to 0.2% by mass.
  • the said content is a total amount of content of all the components F2 contained in a undiluted
  • the stock solution is not particularly limited, but may contain components other than the components A to F (other components).
  • perfumes silicone oils such as cyclopentasiloxane, hydrogen dimethicone, caprylyl methicone, methylphenylpolysiloxane, dimethicone, etc. preservatives such as phenoxyethanol, octoxyglycerin, methyl paraben, etc. menthol, menthyl glyceryl ether, camphor, peppermint oil etc.
  • Cooling agent Anti-inflammatory agent such as dipotassium glycyrrhizinate and stearyl glycyrrhizinate; Extract of plant extract such as peony, peony, loquat, aloe, etc .; Bactericide; Antioxidant such as tocopherol, dibutyl hydroxytoluene; Benzylidene dioxo imidazolidine octyl propionate, diethyl aminohydroxy benzoyl benzoate, t-butyl methoxy dibenzoyl methane, octyl Riazon, ultraviolet absorbents such as 2-ethylhexyl p-methoxycinnamate; chelating agents such as edetate salts; arbutin, whitening agents such as ascorbic acid; silica, talc, may contain such powders such as nylon powder.
  • Anti-inflammatory agent such as dipotassium glycyrrhizinate
  • microbicide examples include isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, dipotassium glycyrrhizinate, and salicylic acid. Among them, isopropylmethylphenol and salicylic acid are more preferable, and salicylic acid is more preferable.
  • the said germicide may use only 1 type and may use 2 or more types.
  • the content of the bactericidal agent in 100% by mass of the stock solution is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and preferably 2.0% by mass or less, more preferably Is 1.0% by mass or less, more preferably 0.5% by mass or less.
  • a bactericidal effect is effectively acquired as content of a germicide is more than the above-mentioned minimum.
  • content of a germicide is below the said upper limit from a viewpoint of safety
  • the above content is the total of the content of all the germicides contained in the stock solution.
  • the ability to form a thick foam in the foam skin cleanser may be reduced, and HLB 9.0 to 13.0 is used for this problem.
  • the foam quality can be improved by additionally containing a polyethylene glycol type nonionic surfactant.
  • the polyethylene glycol type nonionic surfactant has a PEG chain and has an effect of enlarging the hydration layer by coating the surface of the emulsion, so the emulsion particles are more stable. It can be considered that as a result, even in a system to which a bactericidal agent is added, it is possible to form a foam having a better texture without losing the foam quality.
  • a polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 preferably HLB 9.5 to 12.0 from the viewpoint of forming a dense foam.
  • Polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may contain component D of HLB 9.0 to 13.0, polyethylene of HLB 9.0 to 13.0 other than component D It may further contain a glycol type nonionic surfactant.
  • examples of polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 other than the component D include, for example, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil and the like.
  • the polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 may be used alone or in combination of two or more.
  • the content of the polyethylene glycol type nonionic surfactant of HLB 9.0 to 13.0 in 100% by mass of the stock solution forms a firm and dense foam. It is preferably 0.3 to 1.5% by mass, more preferably 0.5 to 1.0% by mass, and still more preferably 0.5 to 0.8% by mass.
  • the above content is the total of the content of polyethylene glycol type nonionic surfactant of all HLBs 9.0 to 13.0 contained in the stock solution.
  • propellant examples include known propellants, for example, gases such as air, nitrogen and nitrous oxide (especially compressed gas); liquefied petroleum gas (LPG: liquefied petroleum gas), dimethyl ether (DME: dimethyl ether) And liquefied gases such as isopentane and fluorocarbon.
  • gases such as air, nitrogen and nitrous oxide (especially compressed gas); liquefied petroleum gas (LPG: liquefied petroleum gas), dimethyl ether (DME: dimethyl ether)
  • liquefied gases such as isopentane and fluorocarbon.
  • the propellant may be used alone or in combination of two or more.
  • the content of the propellant in the total amount of 100% by mass of the undiluted solution and the propellant is preferably 2.0 to 20.0% by mass from the viewpoint of preventing the liquefaction of the discharge. Preferably, it is 3.0 to 15.0% by mass.
  • the "propellant content" means the total amount of individual components constituting the propellant.
  • the foamy skin cleanser of the present invention can be produced by known methods. For example, it is possible to exemplify a manufacturing method in which an undiluted solution is filled in an aerosol container, the container is clinched by an aerosol valve, and then a specified amount of propellant is filled from the stem into the container and the injection button is attached.
  • the foam skin cleanser of the present invention is a skin cleanser used to clean skin such as face.
  • the foam skin cleanser of the present invention includes a cleanser, hand soap, body soap, scalp cleanser and the like.
  • the foam skin cleanser according to the present invention suppresses the feeling of skin firmness after washing and the precipitation of higher fatty acids, and therefore is particularly suitable for use as a cleanser for delicate areas such as face cleansers.
  • Examples 1 to 76 and Comparative Examples 1 to 3 95 parts by mass of the stock solution having the composition described in Tables 1 to 12 is filled in an aerosol container ( ⁇ 35 mm ⁇ 105 mm, aluminum can, container full filling amount: 91 ml) and after clinching the aerosol valve into the container, it is liquefied as a propellant 5 parts by mass of petroleum gas (LPG) was filled from the stem and equipped with a suitable spout to obtain a foamy skin cleanser.
  • LPG petroleum gas
  • the total amount of the undiluted solution and the propellant charged in the aerosol container is 50 g.
  • Myristic acid EDENOR C14-99 (manufactured by Emery Oleochemicals) Palmitic acid: EDENOR C14-99 (manufactured by Emery Oleochemicals)
  • Isononyl isononanoate Saracos 99 (manufactured by Nisshin Oillio Group, Inc.) 2-ethylhexyl palmitate: KOYO POC (manufactured by Kyosho Fine Chemical Co., Ltd.) Cetyl 2-ethylhexanoate: Saracos 816 T (manufactured by Nisshin Oillio Group, Inc.)
  • Octyl dodecyl myristate Excepearl OD-M (manufactured by Kao Corporation)
  • Polyethylene glycol monostearate Emanol 3199 VB (manufactured
  • the foam-like skin cleanser foam of each example and each comparative example was discharged onto a Kim towel (quadruple type: Nippon Paper Cress Co., Ltd.) for 1 second in a dome shape. Then, from the distance of 20 cm away from the top end of the dome-shaped foam, 2 push the purified water filled in the pump container (spray discharge amount: 0.5 mL / 1 push), spray the whole foam, and after 30 seconds Lightly press the surface of the foam with a fingertip, and according to the evaluation points 1 to 4 below, Examples 1 to 20, Comparative Examples 1 and 2 for "foam elasticity", and Examples 21 to 76, Comparative Example 3
  • the sensory evaluation was carried out for “foam elasticity” and “foam quality (density of foam)”. In addition, evaluation was performed by 10 evaluation panels, and the result of the evaluation point (score) obtained most by the number of people was made into the result of each sample. The results are shown in Tables 1-12.
  • the foamy skin cleansers of Examples 1 to 76 containing Component A, Component B, Component C, and Component D have suppression of precipitation of higher fatty acids, detergency, foam elasticity, foam retention, cleansing It was excellent about any of the skin condition (the lack of a feeling of tension) after.
  • Comparative Examples 1 and 3 which do not contain Component B and in the foam skin cleansing agent of Comparative Example 2 which does not contain Component D, precipitation of higher fatty acids was observed.
  • foamy skin containing fatty acid ester oil and sorbitan fatty acid ester type nonionic surfactant which are solid at room temperature It can be seen that the cleaning agent can form a dense foam.
  • foams of Examples 74 and 75 containing polyethylene glycol type nonionic surfactants of HLB 9.0 to 13.0 have the same properties as those of Examples 74 and 75. It turns out that it is preferable.
  • Prescription example 1 (Stock solution) Myristic acid 2.00 Palmitic acid 1.00 Stearic acid 1.00 Triethanolamine 2.90 1,3-butylene glycol 2.00 Polyethylene glycol 2.00 Xanthan gum 0.15 Hydroxypropyl methylcellulose 0.05 Diisopropyl adipate * 1 1.00 Hexa (hydroxystearic acid / stearic acid / rosin acid) dipentaerythrityl 1.00 Coconut oil fatty acid sorbitan 1.00 Polyoxyethylene (20) sorbitan monostearate 1.50 Polyethylene glycol monostearate 1.00 Sorbitol 2.00 Refined water Total 100.00 (Propellant) Liquefied petroleum gas (LPG) 100.00 100.00 in total Undiluted solution 95.00 Propellant 5.00 100.00 in total * 1) Diisopropyl adipate: Matte Lube DIA (manufactured by Seiwa Kasei)
  • Prescription example 2 (Stock solution) Myristic acid 3.00 Triethanolamine 2.35 Dipropylene glycol 4.00 Concentrated glycerin 1.00 Xanthan gum 0.15 Hydroxypropyl cellulose 0.10 Diisobutyl adipate * 2 1.00 Tetra (hydroxystearic acid / isostearic acid) dipentaerythrityl 1.00 Coconut oil fatty acid sorbitan 1.00 Polyoxyethylene (20) sorbitan monostearate 0.75 Polyethylene glycol distearate 0.50 Sorbitol 2.00 Refined water Total 100.00 (Propellant) Liquefied petroleum gas (LPG) 100.00 100.00 in total Undiluted solution 96.00 Propellant 4.00 100.00 in total * 2) Diisobutyl adipate: Matte Lube DIBA (made by Seiwa Kasei)
  • the foamy skin cleanser of the present invention can be used as a cleanser for face, hands, body, scalp and hair.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un nettoyant pour la peau sous forme de mousse qui est tel qu'une solution de base et un gaz propulseur remplissent un contenant, et qui est caractéristique en ce que ladite solution de base comprend les composants (A), (B), (C) et (D). Composant (A) : acide gras supérieur et /ou sel de celui-ci, composant (B) : huile d'ester d'acide gras liquide à température de laboratoire, composant (C) : eau, composant (D) : agent tensio-actif non-ionique type ester d'acide gras de polyéthylène glycol. Ce nettoyant pour la peau sous forme de mousse peut être mis en œuvre dans un nettoyant, ou similaire pour le visage, les mains, le corps, le cuir chevelu et les cheveux.
PCT/JP2018/035298 2017-09-25 2018-09-25 Nettoyant pour la peau sous forme de mousse WO2019059392A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020197033224A KR20190133782A (ko) 2017-09-25 2018-09-25 폼상 피부 세정료
CN201880030689.9A CN110612094A (zh) 2017-09-25 2018-09-25 泡沫状皮肤清洗料

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2017183579 2017-09-25
JP2017183580 2017-09-25
JP2017-183578 2017-09-25
JP2017-183579 2017-09-25
JP2017-183580 2017-09-25
JP2017183578A JP7121476B2 (ja) 2017-09-25 2017-09-25 フォーム状皮膚洗浄料

Publications (1)

Publication Number Publication Date
WO2019059392A1 true WO2019059392A1 (fr) 2019-03-28

Family

ID=65810904

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/035298 WO2019059392A1 (fr) 2017-09-25 2018-09-25 Nettoyant pour la peau sous forme de mousse

Country Status (3)

Country Link
KR (1) KR20190133782A (fr)
CN (1) CN110612094A (fr)
WO (1) WO2019059392A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210061278A (ko) * 2019-11-19 2021-05-27 가부시키가이샤 만다무 피부 세정제 조성물

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7427486B2 (ja) * 2020-03-23 2024-02-05 株式会社マンダム フォーム状皮膚洗浄料
JP7216444B1 (ja) 2021-12-01 2023-02-01 アピ株式会社 外用組成物

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001181609A (ja) * 1999-12-27 2001-07-03 Daizo:Kk エアゾール組成物
JP2002138045A (ja) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd 前駆脂肪細胞分化誘導剤
JP2005097143A (ja) * 2003-09-24 2005-04-14 Kanebo Cosmetics Inc 洗浄用化粧料
JP2010265241A (ja) * 2009-05-18 2010-11-25 Daizo:Kk エアゾール組成物
JP2013159608A (ja) * 2012-02-08 2013-08-19 Masaaki Ishiwatari 界面活性剤フリーの水中油型乳化クレンジング剤組成物
JP2014189530A (ja) * 2013-03-28 2014-10-06 Nof Corp 皮膚洗浄剤組成物
JP2017095393A (ja) * 2015-11-24 2017-06-01 株式会社マンダム フォーム状皮膚洗浄料

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4690863B2 (ja) 2005-11-11 2011-06-01 ポーラ化成工業株式会社 エアゾル剤形の洗顔化粧料
JP2010222323A (ja) * 2009-03-25 2010-10-07 Kumano Yushi Kk メークアップリムーバー化粧品組成物
JP2012102194A (ja) 2010-11-08 2012-05-31 Mikimoto Pharmaceut Co Ltd 水性液体洗浄剤
JP5707225B2 (ja) 2011-05-23 2015-04-22 花王株式会社 エアゾール型皮膚洗浄料
WO2016114390A1 (fr) * 2015-01-16 2016-07-21 株式会社マンダム Lotion nettoyante, produit cosmétique en feuille, et procédé cosmétique
JP6369923B2 (ja) * 2015-03-30 2018-08-08 株式会社マンダム フォーム状化粧料

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001181609A (ja) * 1999-12-27 2001-07-03 Daizo:Kk エアゾール組成物
JP2002138045A (ja) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd 前駆脂肪細胞分化誘導剤
JP2005097143A (ja) * 2003-09-24 2005-04-14 Kanebo Cosmetics Inc 洗浄用化粧料
JP2010265241A (ja) * 2009-05-18 2010-11-25 Daizo:Kk エアゾール組成物
JP2013159608A (ja) * 2012-02-08 2013-08-19 Masaaki Ishiwatari 界面活性剤フリーの水中油型乳化クレンジング剤組成物
JP2014189530A (ja) * 2013-03-28 2014-10-06 Nof Corp 皮膚洗浄剤組成物
JP2017095393A (ja) * 2015-11-24 2017-06-01 株式会社マンダム フォーム状皮膚洗浄料

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210061278A (ko) * 2019-11-19 2021-05-27 가부시키가이샤 만다무 피부 세정제 조성물
CN112891253A (zh) * 2019-11-19 2021-06-04 株式会社漫丹 皮肤清洗剂组合物
CN112891253B (zh) * 2019-11-19 2023-05-02 株式会社漫丹 皮肤清洗剂组合物
KR102529753B1 (ko) * 2019-11-19 2023-05-08 가부시키가이샤 만다무 피부 세정제 조성물

Also Published As

Publication number Publication date
KR20190133782A (ko) 2019-12-03
CN110612094A (zh) 2019-12-24

Similar Documents

Publication Publication Date Title
JP6862069B2 (ja) フォーム状皮膚洗浄料
JP4868148B2 (ja) 液体洗浄剤製品
JP5754644B2 (ja) 液体洗浄剤組成物
WO2011004571A1 (fr) Détergent
JP6683524B2 (ja) 水性クレンジング化粧料
JP6645814B2 (ja) フォーム状皮膚洗浄料
WO2019059392A1 (fr) Nettoyant pour la peau sous forme de mousse
JP6571361B2 (ja) フォーム皮膚洗浄料
JP6795297B2 (ja) フォーム状皮膚洗浄料
JP6237172B2 (ja) 液体洗浄剤組成物
JP4546069B2 (ja) ノンガス型の泡吐出容器入り液体洗浄剤組成物
JP7121618B2 (ja) フォーム状皮膚洗浄料
JP7121617B2 (ja) フォーム状皮膚洗浄料
JP2017193625A (ja) 液体洗浄剤組成物
JP5669522B2 (ja) フォーマー容器入り液体洗浄剤組成物
JP5966642B2 (ja) 皮膚洗浄料
JP2011132221A (ja) 水性液状洗浄剤組成物
JP7463038B2 (ja) 液状皮膚洗浄用組成物
JP7121476B2 (ja) フォーム状皮膚洗浄料
JP5562560B2 (ja) 泡沫洗浄剤
JP2008105989A (ja) 洗浄用の化粧料
JP7427486B2 (ja) フォーム状皮膚洗浄料
JP2019172624A (ja) 皮膚洗浄剤
JP7418920B2 (ja) エアゾール型除毛剤
US10864149B2 (en) Non-aerosol shaving compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18858176

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20197033224

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18858176

Country of ref document: EP

Kind code of ref document: A1